Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × olaparib × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 35 Ovarian Neoplasms 31 Prostatic Neoplasms 18 Fallopian Tube Neoplasms 16 Triple Negative Breast Neoplasms 15 Neoplasm Metastasis 11 Neoplasms 9 Pancreatic Neoplasms 8 Endometrial Neoplasms 8 Small Cell Lung Carcinoma 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 6 Carcinoma, Non-Small-Cell Lung 6 Stomach Neoplasms 5 Sarcoma 5 Glioma 5 Lung Neoplasms 4 Glioblastoma 4 Squamous Cell Carcinoma of Head and Neck 3 Recurrence 3 Metastatic Castration-resistant Prostate Cancer 3 Lymphoma, Non-Hodgkin 3 Cholangiocarcinoma 3 Carcinoma, Ovarian Epithelial 3 Urinary Bladder Neoplasms 2 Solid Tumors 2 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Peritoneal Neoplasms 2 Pathologic Complete Response 2 Osteosarcoma 2

Interventions

Azacitidine 29 venetoclax 21 Cyclophosphamide 17 Whole-Body Irradiation 14 fludarabine phosphate 13 Biopsy 13 fludarabine 12 Tacrolimus 12 Specimen Handling 12 Mycophenolic Acid 11 Decitabine 11 Cytarabine 10 Stem Cell Transplantation 9 Peripheral Blood Stem Cell Transplantation 9 Injections 8 decitabine and cedazuridine drug combination 7 Melphalan 7 Busulfan 6 X-Rays 5 Hematopoietic Stem Cell Transplantation 5 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Cyclosporine 4 sabatolimab 3 olutasidenib 3 enasidenib 3 cedazuridine 3 Sirolimus 3 Rituximab 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡